Capital

Fatal gene-editing trial in China raises ethics and oversight questions

Fatal gene-editing trial in China raises ethics and oversight questions Image: Primary
A six-year-old girl died in China after receiving an experimental brain-directed CRISPR therapy, the journal Science reported Thursday. Science wrote of the death in heart-wrenching detail, according to The Readout. The therapy was described as experimental and directed at the brain. The report raises questions about ethics and oversight of gene-editing trials. The Readout summarized the Science article in its daily biotech newsletter. The newsletter also noted a separate development involving an FDA panel vote on compounding pharmacies. The Readout said it will take a summer break next week and return in August.
Sources
STAT
In this story
China
Published by Tech & Business, a media brand covering technology and business. This story was sourced from STAT and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital AI
Capital AI

Mistral AI reported to be raising €3 billion Series D round

Mistral AI is raising €3 billion ($3.49 billion) in a Series D round, according to Bloomberg Technology, with Samsung Electronics joining the financing. Chief Executive Arthur Mensch said the French AI company is probably still un...

Bloomberg Technology, Mistral AI
Capital AI
Capital AI

Cognition reports $2 billion Series E at $48 billion valuation

Cognition AI said it raised more than $2 billion in a Series E financing at a $48 billion valuation. SiliconANGLE reported that the company's prior May round raised more than $1 billion at a $26 billion valuation and that Cogniti...

SiliconANGLE
Capital
Capital

D-Wave finalizes access to up to $100 million in CHIPS funding

D-Wave Quantum finalized a definitive agreement with the U.S. Department of Commerce providing access to up to $100 million in CHIPS and Science Act funding, following a letter of intent disclosed in May. The company says it will...

Pulse 2.0
Capital
Capital

Molten Ventures closes €203 million growth-tech fund

Molten Ventures announced a €203 million first close for its Growth Fund, intended for Series B and later investments in UK and European technology companies. The British Business Bank committed €87 million as cornerstone investor...

EU-Startups
AI Capital
AI Capital

Anthropic reportedly declines Decart AI acquisition

Anthropic has decided against acquiring AI startup Decart AI, according to people familiar with the matter, Bloomberg reported. The companies may still explore other ways to collaborate, one of the people said. The report does not...

Bloomberg Technology